Katie E. Barber

1 INTRODUCTION Female hypogonadism (FH) results in amenorrhoea with deficient ovarian folliculogenesis, impaired sex hormone secretion, anovulation and, frequently, sexual or vasomotor symptoms during the age range from normal puberty to normal menopause. It is usually characterised biochemically by a persistently low circulating serum 17β-estradiol (estradiol) concentration.

Objectives The purpose of this study was to determine student perceptions versus actual level of test anxiety, as measured by the Cognitive Test Anxiety Scale-2 (CTAS-2), and student and faculty perceptions of test anxiety with regard to prevalence, impact, ease of treatment, and importance in pharmacy education.

Back to Journals » Patient Preference and Adherence » Volume 17 Authors Barber K, Charles A Received 12 July 2023 Accepted for publication 31 October 2023 Published 15 November 2023 Volume 2023:17 Pages 2971—2980 DOI https://doi.org/10.2147/PPA.S430203 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Dr Johnny Chen Katie Barber,1,2 Alexandra Charles3 1Clinical Lead Community Gynaecology, Oxfordshire, UK; 2Clinical...